Millipore Sigma Vibrant Logo

529685 Prodigiosin Serratia marcescens - CAS 82-89-3 - Calbiochem

View This Product on Sigma-Aldrich
529685
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
82-89-3C₂₀H₂₅N₃O

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
529685-200UGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      ガラスビン 200 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA cell-permeable tripyrrole alkaloid compound that displays immunosuppressive and anti-tumor properties irrespective of p53 status and multidrug resistance. Shown to selectively upregulate p21WAF/CIP1 and NAG-1 (nonsteroidal anti-inflammatory drug-activated gene 1) and downregulate survivin expression levels, induce mitochondria-mediated apoptosis and cell cycle arrest in tumor cells. Prevents FADD phosphorylation (IC50 = 2.0 µM in A549-FKR cells) through inhibition of FADD-kinase CK1α (IC50 ~ 6.0 µM in SW620-BGCR cells) and augments cisplatin (Cat. No. 232120)-induced apoptosis. Blocks NF-κB activation by decreasing pIκBα (by 63% at 3 µM) and IκBα levels in A549 cells, and shrinks tumor growth in A549-FKR tumor xenograft mouse model (3 mg/kg, i.p., o.d.).
      Catalogue Number529685
      Brand Family Calbiochem®
      SynonymsCasein Kinase I Inhibitor IV, 2-Methyl-3-pentyl-6-methoxyprodigiosene, NSC 47147
      References
      ReferencesSchinske, K.A., et al. 2011. Mol. Cancer Ther. 10, 1807.
      Chang, C.C., et al. 2011. J. Biosci. Bioeng. 5, 501
      Ho, T.F., et al. 2009. Toxicol. Appl. Pharmacol. 235, 253
      Soto-Cerrato, V., et al. 2007.Mol. Cancer Ther. 6, 362.
      Product Information
      CAS number82-89-3
      FormDark red solid
      Hill FormulaC₂₀H₂₅N₃O
      Chemical formulaC₂₀H₂₅N₃O
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      529685-200UGCN 04055977269314

      Documentation

      Prodigiosin Serratia marcescens - CAS 82-89-3 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Prodigiosin Serratia marcescens - CAS 82-89-3 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      529685

      参考資料

      参考資料の概要
      Schinske, K.A., et al. 2011. Mol. Cancer Ther. 10, 1807.
      Chang, C.C., et al. 2011. J. Biosci. Bioeng. 5, 501
      Ho, T.F., et al. 2009. Toxicol. Appl. Pharmacol. 235, 253
      Soto-Cerrato, V., et al. 2007.Mol. Cancer Ther. 6, 362.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-June-2012 JSW
      SynonymsCasein Kinase I Inhibitor IV, 2-Methyl-3-pentyl-6-methoxyprodigiosene, NSC 47147
      DescriptionA cell-permeable tripyrrole alkaloid compound that displays immunosuppressive and anti-tumor properties irrespective of p53 status and multidrug resistance. Shown to selectively upregulate p21WAF/CIP1 and NAG-1 (nonsteroidal anti-inflammatory drug-activated gene 1) and downregulate survivin expression levels, induce mitochondria-mediated apoptosis and cell cycle arrest in tumor cells. Prevents FADD phosphorylation (IC50 = 2.0 µM in A549-FKR cells) through inhibition of FADD-kinase CK1α (IC50 ~ 6.0 µM in SW620-BGCR cells) and augments cisplatin (Cat. No. 232120)-induced apoptosis. Blocks NF-κB activation by decreasing pIκBα (by 63% at 3 µM) and IκBα levels in A549 cells, and shrinks tumor growth in A549-FKR tumor xenograft mouse model (3 mg/kg, i.p., o.d.).
      FormDark red solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number82-89-3
      Chemical formulaC₂₀H₂₅N₃O
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO, DMF, EtOH, MeOH
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesSchinske, K.A., et al. 2011. Mol. Cancer Ther. 10, 1807.
      Chang, C.C., et al. 2011. J. Biosci. Bioeng. 5, 501
      Ho, T.F., et al. 2009. Toxicol. Appl. Pharmacol. 235, 253
      Soto-Cerrato, V., et al. 2007.Mol. Cancer Ther. 6, 362.